Michelle Dawson posts

Post published on Twitter/X on 11 May 2021 03:24

Twitter/X DOI work crossref Extract quoted in the post Question asked by Dawson in the post External link integrated into the post Autism terms

Structured cited links

1 cited resource

DOI work Fetched Post crossref

Chantel Ritter, Katherine Hewitt, Carly A. McMorris (2021). Psychotropic Polypharmacy Among Children and Youth with Autism: A Systematic Review. Journal of Child and Adolescent Psychopharmacology, 31(4), 244-258. SAGE Publications.

Publication date
1 May 2021
Identifier
10.1089/cap.2020.0110
Authors
Chantel Ritter, Katherine Hewitt, Carly A. McMorris
Source
Journal of Child and Adolescent Psychopharmacology
Details
31(4), 244-258
Reference type
article
Publisher
SAGE Publications
Metadata source
crossref

Abstract

Objectives: Majority of youth with autism are taking two or more medications (psychotropic or nonpsychotropic) simultaneously, also known as polypharmacy. Yet the efficacy and the potential outcomes of polypharmacy in this population are widely unknown. This systematic literature review described the trends of polypharmacy among autistic youth, and identified factors associated with polypharmacy. Methods: Sixteen studies were included, encompassing over 300,000 youth with autism. Results: Rates of polypharmacy varied quite substantially across studies, ranging from 6.8% to 87% of autistic youth. Having psychiatric comorbidities, self-injurious behaviors, and physical aggression, as well as being male and older, were associated with higher rates of polypharmacy. Conclusion: Findings emphasize the importance of further research to determine appropriate practices related to the monitoring of adverse side effects, and the long-term impact of polypharmacy among autistic youth.

Study authors in this cited reference